Alnylam Presents New Pre-clinical Data on RNAi Therapeutics at American Heart Association Meeting
November 17, 2013 at 16:54 PM EST
-- Alnylam Pharmaceuticals (NASDAQ: ALNY ) announced today that it has presented new pre-clinical data from two RNAi therapeutic programs for cardiovascular disease, including: ALN-PCSsc, an RNAi therapeutic targeting